Squarex, LLC   Report issue

For profit Phase 2
Founded: St Paul MN United States (2017)

Organization Overview

First Clinical Trial
2017
NCT02965781
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Squarex, LLC

Active Ingredients

Drugs in Phase 2 Trials (1)

squaric acid dibutylester (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Herpes Labialis (Phase 2)

Herpes Simplex (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1